Tag Archives: Severe

Gene related to where a person lives ‘could prevent severe reaction to Covid’

Have you ever wondered why some people who catch Covid only have a mild illness, while others become seriously ill? Well, a scientific and medical team at Newcastle University have shown that a particular gene, called HLA-DRB1*04:01, is found three times more often in people who are asymptomatic, suggesting this gene confers some level of… Read More »

Zambian study finds no link between HIV status and COVID-19 severity, but risk quadruples for people with severe HIV infection

Having HIV is not an independent risk factor for severe COVID-19 and death amongst patients hospitalised with COVID-19, according to a Zambian study published in the Morbidity and Mortality Weekly Report. However, patients with more severe HIV infection are more likely to develop severe COVID-19 or die of COVID-19 compared to those without complications. “This… Read More »

Sleep Apnea Raises Odds for Severe COVID-19

TUESDAY, May 18, 2021 (HealthDay News) — People suffering from severe obstructive sleep apnea are at a greater risk of catching COVID-19, a new study finds. But researchers at Kaiser Permanente Southern California also found that the longer patients used a continuous positive airway pressure (CPAP) mask while sleeping, the more their COVID-19 risk dropped.… Read More »

Use of Dexamethasone to Treat Trump Suggests Severe Covid-19, Experts Say

President Trump’s doctors offered rosy assessments of his condition on Sunday, but the few medical details they disclosed — including his fluctuating oxygen levels and a decision to begin treatment with a steroid drug — suggested to many infectious disease experts that he is suffering a more severe case of Covid-19 than the physicians acknowledged.… Read More »

FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain

FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain Print this page ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Qdolo™ (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults… Read More »